Access Statistics for Margaret K. Kyle

Author contact details at EconPapers.

Working Paper	File Downloads				Abstract Views
Working Paper	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Competition and the Efficiency of Markets for Technology	0	0	1	70	0	0	2	129
Competition and the Efficiency of Markets for Technology	0	0	0	94	0	0	2	135
Did U.S. Bank Supervisors Get Tougher During the Credit Crunch? Did They Get Easier During the Banking Boom? Did It Matter to Bank Lending?	0	0	0	189	0	0	2	819
Did U.S. bank supervisors get tougher during the credit crunch? Did they get easier during the banking boom? Did it matter to bank lending?	0	0	0	138	0	0	1	532
Inefficiencies in technology transfer: theory and empirics	0	0	0	13	0	2	3	97
Inefficiencies in technology transfer: theory and empirics	0	0	0	58	0	1	1	326
Inefficiencies in the sale of ideas: theory and empirics	0	0	0	106	0	1	2	118
Intellectual Property Rights and Access to Innovation: Evidence from TRIPS	1	1	6	61	2	3	17	196
Investments in Pharmaceuticals Before and After TRIPS	0	0	0	88	0	0	3	261
Investments in Pharmaceuticals Before and After TRIPS	1	1	2	41	2	3	5	157
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs	0	0	1	45	0	2	4	59
Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research	0	1	1	125	0	1	3	365
Strategic Responses to Parallel Trade	0	0	0	131	0	0	1	392
The More We Die, The More We Sell? A Simple Test of the Home-Market Effect	0	0	0	23	0	1	5	89
Total Working Papers	2	3	11	1,182	4	14	51	3,675

Journal Article	File Downloads				Abstract Views
Journal Article	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Deregulating Direct-to-Consumer Marketing of Prescription Drugs: Effects on Prescription and Over-the-Counter Product Sales	0	0	3	29	0	1	9	136
Does locale affect R&D productivity? the case of pharmaceuticals	0	0	1	26	0	2	4	97
Generic competition and market exclusivity periods in pharmaceuticals	0	2	11	177	4	14	40	468
Intellectual Property Protection and the Geography of Trade	0	0	0	40	2	2	6	210
Investments in Pharmaceuticals Before and After TRIPS	1	2	9	186	1	8	25	568
Pharmaceutical Price Controls and Entry Strategies	0	1	5	531	0	4	19	1,202
Strategic Responses to Parallel Trade	0	0	1	96	0	0	4	353
The role of firm characteristics in pharmaceutical product launches	0	0	0	21	0	0	1	82
Total Journal Articles	1	5	30	1,106	7	31	108	3,116

Chapter	File Downloads				Abstract Views
Chapter	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Did US Bank Supervisors Get Tougher during the Credit Crunch? Did They Get Easier during the Banking Boom? Did It Matter to Bank Lending?	0	1	1	45	0	1	5	170
Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research	0	0	0	0	0	0	0	91
The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals	0	0	0	19	0	1	1	60
The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches	0	0	1	105	0	0	4	324
Total Chapters	0	1	2	169	0	2	10	645

Software Item	File Downloads				Abstract Views
Software Item	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
MATLAB/C code for GIG and BNLG common value auction specifications	1	1	2	1,672	1	1	11	5,709
Total Software Items	1	1	2	1,672	1	1	11	5,709

Authors with papers registered in the RePEc Author Service.

Authors with no registered papers

LogEc provides access and usage statistics for services based on the RePEc data set.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2025-05-12